Patent Number: 8,871,723

Title: Glycan modified soluble receptors and binding protein and their use

Abstract: An invention relates to a glycan-modified soluble receptor or binding protein of a cytokine, growth factor, lipoprotein or oxidized lipoprotein, modified to carry a terminal Gal, GlcNAc or GalNAc.

Inventors: Rubinstein; Menachem (Rehovot, IL), Werman; Ariel (Jerusalem, IL), Alkahe; Ben (Tel Aviv, IL)

Assignee: Yeda Research and Development Co. Ltd.

International Classification: A61K 38/16 (20060101); C07K 14/00 (20060101)

Expiration Date: 2018-10-28 0:00:00